Aller au contenu principal
  • Partenaires agréés
  • À propos d'ELGA
    • À propos d'ELGA
    • Carrières
    • Événements
  • Assistance
    • Aménagement du laboratoire
    • Enregistrer un produit
    • Register Your Product (USA & Canada Only)
  • Contact
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • Italia
  • Brasil
  • 日本
  • 中国
Accueil ELGA LabWater
  • Produits
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • Gamme complète des produits ELGA
  • Applications
    • Analyse microbiologique
    • Biochimie clinique
    • Chromatographie en phase gazeuse
    • Chromatographie en phase liquide
    • Exigences générales d'un laboratoire en matière d'eau
    • Génétique
    • Immunochimie
    • Spectrométrie de masse
    • Spectrophotométrie
    • Spectroscopie atomique
    • Électrochimie
  • Technologies
    • Charbon actif
    • Filtration
    • Osmose inverse
    • PureSure
    • Ultraviolet
    • Échange ionique
    • Électrodéionisation (EDI)
  • Impuretés dans l'eau
    • Composés inorganiques
    • Composés organiques
    • Gaz dissous
    • Micro-organismes et bactéries
    • Particules
  • Knowledge
    • Blog
    • Études de cas
    • Eau ultra-pure
    • Guides et livres blancs
  • Produits
    • PURELAB
    • CENTRA
    • MEDICA
      • Hubgrade
      • MEDICA BIOX
    • BIOPURE
    • Gamme complète des produits ELGA
      • PURELAB® Classic
  • Applications
    • Analyse microbiologique
    • Biochimie clinique
    • Chromatographie en phase gazeuse
    • Chromatographie en phase liquide
      • Hochleistungsflüssigkeitschromatographie (HPLC)
    • Exigences générales d'un laboratoire en matière d'eau
    • Génétique
    • Immunochimie
    • Spectrométrie de masse
    • Spectrophotométrie
    • Spectroscopie atomique
    • Électrochimie
  • Technologies
    • Charbon actif
    • Filtration
    • Osmose inverse
    • PureSure
    • Ultraviolet
    • Échange ionique
    • Électrodéionisation (EDI)
  • Impuretés dans l'eau
    • Composés inorganiques
    • Composés organiques
    • Gaz dissous
    • Micro-organismes et bactéries
    • Particules
  • Knowledge
    • Blog
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • Études de cas
      • Abbott Diagnostics opte pour les systèmes ELGA MEDICA en Asie du Sud
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Argenta chooses DKSH New Zealand to deliver Ultrapure water in Animal Pharma
      • Clean Water for a Clean Future
      • LS Scientific & ELGA deliver UltraPure water to the NAFDAC Laboratory
      • Lifebrain Group chooses ELGA as water partner for new modern 24/7 PCR-COVID-19 laboratory in Vienna, Austria.
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA : la plus grande société de diagnostic médical au Brésil
      • ELGA aide les laboratoires d'immuno-sérologie à maximiser la disponibilité
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • Importance de l'eau ultra-pure de type 1+ pour la mise au point de médicaments génériques
      • MEDICA® Pro sélectionné pour les analyseurs Siemens ADVIA® à l'hôpital général de la ville
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex : un système de formation idéal pour la méthode de recherche actuelle
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • Découvrir les secrets de l'Antarctique à l'aide d'eau ultra-pure
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • Eau ultra-pure
    • Guides et livres blancs
      • Pureté de l'eau pour la HPLC
      • HPLC dans le secteur pharmaceutique
      • Réduire les risques cliniques
      • Durabilité
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • Italia
  • Brasil
  • 日本
  • 中国
  • Politique relative à la confidentialité
  • Conditions générales
  • Conformité juridique mondiale
  • Brevets
  • Impressum
  • Accueil
  • A Step Towards a Non–Invasive Test for Monitoring Patients with Heart Failure
Analytical Chemistry
Science of the Future

A Step Towards a Non–Invasive Test for Monitoring Patients with Heart Failure

24 aoû 2020
- by Dr Alison Halliday

Close up of doctor with sample of saliva from sick womanResearchers demonstrate the potential of using saliva analysis to predict flare-ups in people with heart failure, which could help them to live longer and better lives. 

At least 26 million people worldwide are currently living with heart failure – and these numbers are expected to increase dramatically in the future. 

When a person first develops heart failure, their body will undergo several physiological changes to try and compensate. But eventually, their body can no longer keep up and they start to experience symptoms such as shortness of breath and fatigue. Their condition will progressively worsen over time – and around four in ten patients will not survive for more than five years after their diagnosis.

A person living with heart failure may experience acute heart failure, which will often require hospital admission. If doctors could reliably predict an imminent flare-up, it may be possible to prevent it from happening – improving the quality of life for people living with heart failure and potentially lengthening their lives.

A Non–Invasive Test

In a new study, published in Scientific Reports, researchers carry out a pilot study to investigate the feasibility of monitoring patients with heart failure by testing their saliva.1

The researchers developed a new method to simultaneously measure the concentration of two potential biomarkers – 8–isoPGF2α and cortisol – in saliva. This involved combining microextraction by packed sorbent (MEPS) with ultra–high–performance liquid chromatography coupled to electrospray ionization triple–quadrupole mass spectrometry (UHPLC–ESI–MS/MS).

They demonstrated that this approach provided satisfactory recovery (95–110%) and an adequate detection limit (10pg/ml) in saliva samples. 

Monitoring Patients with Heart Failure

The team then carried out a pilot study on saliva samples from 44 patients with heart failure who were hospitalized due to a flare-up. They used validated procedures to monitor a panel of candidate biomarkers for heart failure – lactate, uric acid, TNF–α, cortisol, α–amylase and 8–isoPGF2α – collected at regular times during their stay.

They measured the concentration of TNF–α with an enzyme-linked immunosorbent assay (ELISA) using ultrapure water obtained from an ELGA PURELAB® laboratory water purification system, minimising the risk of introducing contaminants that may affect their results.

Their results identified that about 70% of patients showed at least a 3–fold decrease of two biomarkers – 8–isoPGF2α and lactate – in their saliva at the point of discharge from hospital, which is likely related to an improvement in clinical symptoms due to treatment. Assuming that high salivary concentrations of these two chemicals build up progressively over time in saliva, their monitoring may provide an early warning of acute heart failure.

Preventing Flare-Ups

This study identifies 8–isoPGF2α and lactate as possible non–invasive biomarkers for heart failure monitoring – and that saliva analysis has potential applications in clinical practice. 

If these biomarkers are validated in future studies, it could pave the way towards the development of new sensing devices that could be used at home to help prevent flare-ups in patients with heart failure – improving and possibly prolonging their lives. 

Why choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. We believe in giving you choice in how you use our water purification solutions, supported by excellent service and support.
 

Reference:

1. Ghimenti S., et al. Salivary lactate and 8–isoprostaglandin F2α as potential non–invasive biomarkers for monitoring heart failure: a pilot study. Sci Rep (2020):10;7441. https://doi.org/10.1038/s41598-020-64112-2

 

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

Quest Download

PURELAB Quest

The only purifier on the market that dispenses all 3 types of science ready water from a compact, economical and easy to use system!

             Click Here To Find Out More

 

  • Enquiry
  • Obtenir un devis
  • Réservez une démo
  • Trouver un partenaire approuvé

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Obtenir un devis

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Réservez une démo

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Head Quarters

Lane End Business Park
Lane End, High Wycombe
HP14
3BY Royaume-Uni
T : +44 (0) 203 567 7300 - Fax
 : +44 (0) 203 567 7205

Siège social ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14
3BY Royaume-Uni
T : +44 (0) 203 567 7300 - Fax
 : +44 (0) 203 567 7205

Études de cas

  • Diagnostics Abbott
  • Diagnostics médicaux DASA
  • Institut médical NeoDIN
  • Fondation North Staffordshire NHS Trust
  • Lycée professionnel d'Olsberg

Ressources

  • En savoir plus sur l'eau ultra-pure
  • Guides et livres blancs
  • Technologies de purification
  • Applications
  • Impuretés dans l'eau

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • Langue
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Autres sites Veolia
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

© VWS (UK) Ltd. exerçant sous le nom ELGA LabWater.2022-Tous les droits sont réservés.
ELGA est la marque mondiale d'eau de laboratoire de Veolia.

  • Politique relative à la confidentialité
  • Conditions générales
  • Conformité juridique mondiale
  • Brevets
  • Impressum
Elga Veolia
TOP

© 2017 ELGA Veolia